| Medical and Health Sciences | Lifetime | 494 | DE 15 | 99.98 |
| Medical and Health Sciences | 2021-2025 | 569 | DE 36 | 99.88 |
| Hepatology | Lifetime | 39 | DE 3 | 99.75 |
| Epidemiology | Lifetime | 318 | DE 17 | 99.61 |
| Urban Design and Landscape Architecture | Lifetime | 130 | DE 8 | 98.15 |
| Oncology | Lifetime | 431 | DE 15 | 99.26 |
| Pulmonary and Respiratory Medicine | Lifetime | 818 | DE 40 | 98.72 |
| Nephrology | Lifetime | 775 | DE 33 | 88.12 |
| Reproductive Medicine | Lifetime | 979 | DE 24 | 83.86 |
| Pharmacology | Lifetime | 918 | DE 53 | 80.00 |
| Gastroenterology | Lifetime | 669 | DE 32 | 77.29 |
| Clinical Biochemistry | Lifetime | 930 | DE 53 | 42.18 |
| Hepatology | 2021-2025 | 14 | DE 3 | 99.74 |
| Epidemiology | 2021-2025 | 215 | DE 9 | 98.45 |
| Oncology | 2021-2025 | 196 | DE 14 | 98.45 |
| Hepatocellular Carcinoma Treatment and Prognosis | Lifetime | 15 | DE 1 | 99.89 |
| Cancer Mechanisms and Therapy | Lifetime | 9 | DE 1 | 99.69 |
| Liver Disease Diagnosis and Treatment | Lifetime | 125 | DE 10 | 99.78 |
| Hepatitis B Virus Studies | Lifetime | 76 | DE 6 | 99.71 |
| Liver physiology and pathology | Lifetime | 48 | DE 7 | 99.32 |
| Colorectal Cancer Treatments and Studies | Lifetime | 194 | DE 5 | 99.31 |
| Cell death mechanisms and regulation | Lifetime | 106 | DE 9 | 99.02 |
| Gastric Cancer Management and Outcomes | Lifetime | 509 | DE 28 | 98.90 |
| Hepatitis C virus research | Lifetime | 406 | DE 26 | 98.82 |
| Cancer Immunotherapy and Biomarkers | Lifetime | 600 | DE 31 | 98.68 |
| Pancreatic and Hepatic Oncology Research | Lifetime | 647 | DE 47 | 98.54 |
| Liver Disease and Transplantation | Lifetime | 488 | DE 28 | 98.72 |
| Cholangiocarcinoma and Gallbladder Cancer Studies | Lifetime | 589 | DE 25 | 97.79 |
| Architecture and Computational Design | Lifetime | 72 | DE 4 | 96.56 |
| Liver Diseases and Immunity | Lifetime | 307 | DE 24 | 97.61 |
| Drug-Induced Hepatotoxicity and Protection | Lifetime | 479 | DE 31 | 96.63 |
| Trace Elements in Health | Lifetime | 753 | DE 38 | 96.26 |
| Aluminum toxicity and tolerance in plants and animals | Lifetime | 241 | DE 11 | 96.31 |
| BIM and Construction Integration | Lifetime | 956 | DE 21 | 93.16 |
| Whipple's Disease and Interleukins | Lifetime | 676 | DE 61 | 59.64 |
| Thallium and Germanium Studies | Lifetime | 981 | DE 97 | 37.55 |
| Hepatocellular Carcinoma Treatment and Prognosis | 2021-2025 | 11 | DE 2 | 99.84 |
| Liver Disease Diagnosis and Treatment | 2021-2025 | 109 | DE 7 | 99.42 |
| Colorectal Cancer Treatments and Studies | 2021-2025 | 68 | DE 1 | 98.93 |
| Cancer Immunotherapy and Biomarkers | 2021-2025 | 282 | DE 8 | 98.92 |
| Cancer Mechanisms and Therapy | 2021-2025 | 34 | DE 3 | 96.92 |
| Liver Disease and Transplantation | 2021-2025 | 240 | DE 10 | 97.48 |
| Pancreatic and Hepatic Oncology Research | 2021-2025 | 542 | DE 34 | 96.06 |
| Hepatitis C virus research | 2021-2025 | 298 | DE 18 | 95.21 |
| Cholangiocarcinoma and Gallbladder Cancer Studies | 2021-2025 | 906 | DE 46 | 88.40 |
| Hepatitis B Virus Studies | 2021-2025 | 924 | DE 33 | 87.73 |
| Liver physiology and pathology | 2021-2025 | 386 | DE 17 | 79.95 |
| Drug-Induced Hepatotoxicity and Protection | 2021-2025 | 471 | DE 12 | 80.75 |